| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 09/27/2001 | US20010025108 Thrombosis diseases |
| 09/27/2001 | US20010025052 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 09/27/2001 | US20010025007 Contacting one or more olefin monomers with a Group 8-10 transition metal complex catalyst and optionally a Bronsted or Lewis acid |
| 09/27/2001 | US20010024749 Surface modified carbonaceous materials |
| 09/27/2001 | DE10014298A1 Reduction of aliphatic, aromatic or heteroaromatic organic compounds comprises mixing the organic compound in liquid or dissolved form with a hydride in liquid or dissolved form in a microreactor |
| 09/27/2001 | CA2404236A1 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | CA2403823A1 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | CA2403778A1 Carbocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | CA2401728A1 Difluorobutyric acid metalloprotease inhibitors |
| 09/26/2001 | EP1135378A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
| 09/26/2001 | EP1135377A1 Novel compounds |
| 09/26/2001 | EP0795326B1 Ocular tension depressant |
| 09/26/2001 | CN1314899A Retinoid-associated receptor regulators |
| 09/26/2001 | CN1314880A Novel method for preparing optically active alpha-aminonitriles |
| 09/26/2001 | CN1314349A Metronizole succinic acid monoester sodium and potassium salt and preparing method and use |
| 09/26/2001 | CN1314348A Method for synthesizing hexanolactam by using titanium silicon molecular sieve to catalyze gas phase rearrangement of cyclohexanone-oxime |
| 09/26/2001 | CN1314185A Tissue anoxia developing agent and its precursor |
| 09/25/2001 | US6294675 Chemical intermediate |
| 09/25/2001 | US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure |
| 09/25/2001 | US6294566 Imidazoline derivatives and uses thereof |
| 09/25/2001 | US6294562 Salts of ethyl 3-(2-(4-(4-amino-imino-methyl)phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)acetylamino)-3-phenylpropionate |
| 09/25/2001 | US6294558 Antiinflammatory agents and prostaglantins |
| 09/25/2001 | US6294517 Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
| 09/25/2001 | US6294185 Monomeric and polymeric cyclic amine and N-halamine compounds |
| 09/25/2001 | US6294069 Method for preparing 2-aryl or 2-heterocyclyl chiral propionic acids and their esters |
| 09/25/2001 | CA2213404C Use of angiogenesis suppressors for inhibiting hair growth |
| 09/20/2001 | WO2001068654A2 Tubulin binding ligands and corresponding prodrug constructs |
| 09/20/2001 | WO2001068619A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | WO2001068610A1 Imidazolylbenzophenone derivatives |
| 09/20/2001 | WO2001068605A1 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
| 09/20/2001 | WO2001068600A2 Benzylated pde4 inhibitors |
| 09/20/2001 | WO2001068599A2 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 09/20/2001 | WO2001068585A1 Novel amide compounds |
| 09/20/2001 | WO2001068535A1 Rapidly-dissolving halogenated hydantoin powders having improved flow, reduced dust, improved wetability, and increased bulk densities |
| 09/20/2001 | WO2000071506A9 Naphthalene ureas as glucose uptake enhancers |
| 09/20/2001 | WO2000047553A8 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa |
| 09/20/2001 | WO2000027378A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 09/20/2001 | US20010023302 Process for producing optically active hemiesters |
| 09/20/2001 | US20010023292 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4 -(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine, for example |
| 09/20/2001 | US20010023291 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 09/20/2001 | EP1143960A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 09/20/2001 | CA2403093A1 Rapidly-dissolving halogenated hydantoin powders having improved flow, reduced dust, improved wetability, and increased bulk densities |
| 09/20/2001 | CA2403017A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | CA2402746A1 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 09/20/2001 | CA2402384A1 Benzylated pde4 inhibitors |
| 09/19/2001 | EP1134759A2 Electrolyte composition for photo-electrochemical cells |
| 09/19/2001 | EP1134215A1 2-oxo-imidazolidine-4-carboxylic acid hydroxamine compounds that inhibit matrix metalloproteinases |
| 09/19/2001 | EP1133476A1 Iminoguanidine derivatives, preparation method, use as medicines |
| 09/19/2001 | EP0880522B1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES AMPA AND NMDA RECEPTORS ANTAGONISTS, PREPARATION THEREOF, INTERMEDIATES THEREOF AND DRUGS CONTAINING SAME |
| 09/19/2001 | EP0839144B1 Piperazine derivatives as therapeutic agents |
| 09/19/2001 | EP0612244B1 Endothelin receptor antagonists |
| 09/19/2001 | CN1313889A Amphoteric derivatives of aliphatic polyamines with fatty acids, esters or triglycerides |
| 09/19/2001 | CN1071356C Water-absorbent resin, production thereof, and water-absorbent resin composition |
| 09/19/2001 | CN1071331C Anti-helicobacter acyl derivatives of azolones |
| 09/19/2001 | CN1071330C Anti-helicobacter urea and thiourea derivatives of azolones |
| 09/19/2001 | CN1071328C Arginine angalogues having nitric oxide synthase inhibitor activity |
| 09/18/2001 | US6291693 Used in assays for the presence of vitamin d, vitamin d analogs and their metabolites which may be present in milk, blood or other biological fluids |
| 09/18/2001 | US6291681 Reacting meso-2,3-bis(benzylamino)succinic acid dialkali metal salt with phenyl chloroformate; acidification, isolating 2-oxo-1,3-dibenzyl-cis-4,5-imidazolidinedicarboxylic acid; heating with acetic anhydride to produce anhydride compound |
| 09/18/2001 | US6291678 Process for the preparation of chiral keto-heterocycles of basic amino acids |
| 09/18/2001 | US6291503 β-phenylalanine derivatives as integrin antagonists |
| 09/18/2001 | US6291502 Use of 2-imidazolyl-substituted carbinols for the production of a medicament for the treatment or phophylaxis of diseases caused by ischemic conditions |
| 09/18/2001 | US6291500 Administering an antifungal agent |
| 09/18/2001 | US6291400 Herbicidal compounds |
| 09/18/2001 | CA2039056C 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
| 09/13/2001 | WO2001066646A1 A method of colouring hair using cationic dyes |
| 09/13/2001 | WO2001066534A2 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
| 09/13/2001 | WO2001066527A1 Substituted benzoylcyclohexenones |
| 09/13/2001 | WO2001012615A3 Fungicidal heteroaryl hepta-2,6-dienoic acid derivatives |
| 09/13/2001 | WO2000059883A3 Method for producing n-aryl-aza-heterocycles in the presence of cesium carbonate |
| 09/13/2001 | US20010021716 Using agonist of nicotinergic acetylcholine receptors |
| 09/13/2001 | US20010021708 Acylurea compound containing imidazolidine ring |
| 09/13/2001 | US20010021388 Cyclization of a triether with a diamine compound |
| 09/13/2001 | DE10028687A1 New benzoyl substituted thio-cyclohexenone derivatives useful as herbicides, especially for weed control in crops |
| 09/13/2001 | CA2401903A1 Substituted benzoylcyclohexenones |
| 09/13/2001 | CA2400337A1 A method of colouring hair using cationic dyes |
| 09/12/2001 | EP1131315A1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
| 09/12/2001 | EP0888317B1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 09/12/2001 | EP0790987B1 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 09/11/2001 | US6288267 Thioamide derivatives |
| 09/11/2001 | US6288247 Catalytic multistage process forming a racemic mixture of compounds |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288231 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 09/11/2001 | US6288230 2-(2, 3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands |
| 09/11/2001 | US6288151 Alkylated aminoalkyl cyclic urea surfactants |
| 09/11/2001 | US6288090 Pharmaceutical composition |
| 09/11/2001 | US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/11/2001 | US6288071 1-ethylene-2-alkylene-1,4-cyclohexadiene pesticides |
| 09/11/2001 | US6288061 Imidazole derivatives |
| 09/11/2001 | US6287483 Mixing with aminopyrrolidine compound |
| 09/11/2001 | CA2015366C Pesticidal 1-arylimidazoles |
| 09/07/2001 | WO2001064671A2 Haloimidazole derivatives and their use as muscarinic m3 and serotoninergic 5-ht4 receptors |
| 09/07/2001 | WO2001064638A1 METHOD FOR PRODUCING β-ALANINAMIDES |
| 09/07/2001 | WO2001064631A2 Derives de polyfluoroalkylimidazole et leur utilisation en tant qu'antagonistes des recepteur muscariniques m3 et serotoniques 5-ht4 |
| 09/07/2001 | WO2001010841A3 Fluorene derivatives as integrin inhibitors |
| 09/06/2001 | US20010020101 Process for preparing biotin |
| 09/06/2001 | US20010020097 Treatment of Alzheimer's disease |
| 09/06/2001 | US20010020021 Metalloprotease inhibitor |
| 09/06/2001 | US20010020013 Polymerase inhibitors |
| 09/05/2001 | EP1129120A1 Modified isocyanates |
| 09/05/2001 | EP1129075A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |